Asia Pacific Diabetes Care Devices Market Outlook to 2017: Glucose Monitoring and Insulin Delivery

2011-12-23
Published : Dec-2011

GlobalData’s new report, Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Asia-Pacific Diabetes Care Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Asia-Pacific Diabetes Care Devices Market Outlook to 2017

Published:December 2011
No. of Pages: 105

$3500

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Countries covered include Australia, China, India and Japan.
  • Market size and company share data for  Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
  • 2010 company shares and distribution shares data for each of the market categories and countries.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices  market..
  • Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, LifeScan, Inc., Eli Lilly and Company, ARKRAY, Inc., Medtronic, Inc.  and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised   for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices   competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 11
2.1 What is This Report About? 11

3 Diabetes Care Devices in Asia-Pacific 12
3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 12
3.2 Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
3.3 Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
3.4 Diabetes Care Devices, Asia-Pacific, Company share (2009-2010) 19

4 Diabetes Care Devices In Japan 21
4.1 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
4.2 Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
4.3 Diabetes Care Devices, Japan, Distribution Share (2009-2010) 28
4.3.1 Glucose Monitoring, Japan, Distribution Share (2009-2010) 28
4.3.2 Insulin Delivery, Japan, Distribution Share (2009-2010) 28
4.4 Diabetes Care Devices, Japan, Company Share (2009-2010) 29
4.4.1 Diabetes Care Devices, Japan, Company Share (2009-2010) 29
4.4.2 Glucose Monitoring, Japan, Company share (2009-2010) 31
4.4.3 Insulin Delivery, Japan, Company share (2009-2010) 33

5 Diabetes Care Devices In India 35
5.1 Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
5.2 Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
5.3 Diabetes Care Devices, India, Distribution Share (2009-2010) 41
5.3.1 Glucose Monitoring, India, Distribution Share (2009-2010) 41
5.3.2 Insulin Delivery, India, Distribution Share (2009-2010) 41
5.4 Diabetes Care Devices, India, Company share (2009-2010) 42
5.4.1 Diabetes Care Devices, India, Company share (2009-2010) 42
5.4.2 Glucose Monitoring, India, Company share (2009-2010) 44
5.4.3 Insulin Delivery, India, Company share (2009-2010) 46

6 Diabetes Care Devices In Australia 47
6.1 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
6.2 Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
6.3 Diabetes Care Devices, Australia, Distribution Share (2009-2010) 55
6.3.1 Glucose Monitoring, Australia, Distribution Share (2009-2010) 55
6.3.2 Insulin Delivery, Australia, Distribution Share (2009-2010) 55
6.4 Diabetes Care Devices, Australia, Company share (2009-2010) 56
6.4.1 Diabetes Care Devices, Australia, Company share (2009-2010) 56
6.4.2 Glucose Monitoring, Australia, Company share (2009-2010) 58
6.4.3 Insulin Delivery, Australia, Company share (2009-2010) 60

7 Diabetes Care Devices In China 62

7.1 Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
7.2 Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
7.3 Diabetes Care Devices, China, Distribution Share (2009-2010) 72
7.3.1 Glucose Monitoring, China, Distribution Share (2009-2010) 72
7.3.2 Insulin Delivery, China, Distribution Share (2009-2010) 72
7.4 Diabetes Care Devices, China, Company share (2009-2010) 73
7.4.1 Diabetes Care Devices, China, Company share (2009-2010) 73
7.4.2 Glucose Monitoring, China, Company share (2009-2010) 75
7.4.3 Insulin Delivery, China, Company share (2009-2010) 77

8 Overview of Key Companies in Asia-Pacific Diabetes Care Devices Market 79
8.1 F. Hoffmann-La Roche Ltd. 79
8.1.1 Company Overview 79
8.1.2 Share in the Asia-Pacific Diabetes Care Devices Market 79
8.2 Novo Nordisk A/S 80
8.2.1 Company Overview 80
8.2.2 Share in the Asia-Pacific Diabetes Care Devices Market 80
8.3 LifeScan, Inc. 81
8.3.1 Company Overview 81
8.3.2 Share in the Asia-Pacific Diabetes Care Devices Market 81
8.4 Eli Lilly and Company 82
8.4.1 Company Overview 82
8.4.2 Share in the Asia-Pacific Diabetes Care Devices Market 82
8.5 ARKRAY, Inc. 83
8.5.1 Company Overview 83
8.5.2 Share in the Asia-Pacific Diabetes Care Devices Market 83
8.6 Medtronic, Inc. 84
8.6.1 Company Overview 84
8.6.2 Share in the Asia-Pacific Diabetes Care Devices Market 84
8.7 Sanofi 85
8.7.1 Company Overview 85
8.8 Abbott Laboratories 85
8.8.1 Company Overview 85
8.9 Bayer HealthCare AG 85
8.9.1 Company Overview 85
8.10 Terumo Corporation 86
8.10.1 Company Overview 86
8.11 Becton, Dickinson and Company 86
8.11.1 Company Overview 86
8.12 Animas Corporation 86
8.12.1 Company Overview 86
8.13 Hindustan Syringes & Medical Devices Ltd. 87
8.13.1 Company Overview 87
8.14 NIPRO CORPORATION 87
8.14.1 Company Overview 87
8.15 B. Braun Melsungen AG 87
8.15.1 Company Overview 87

9 Diabetes Care Devices Market Pipeline Products 88

10 Financial Deals Landscape 91
10.1 Partnerships 91
10.1.1 PositiveID Enters Into Agreement with HMD BioMedical 91
10.1.2 Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 92
10.1.3 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 93

11 Recent Developments 94
11.1 Strategy and Business Planning 94
11.1.1 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 94
11.1.2 Sep 06, 2011: Golden Meditech Launches Representative Office In Taiwan 94
11.1.3 Jun 22, 2011: Johnson & Johnson Opens Innovation Center In China 95
11.1.4 May 12, 2011: MicroPort Establishes Wholly Owned Subsidiary In Jiaxing, China 95
11.1.5 Apr 28, 2011: Takeda Announces Establishment Of New Sales And Marketing Company In China 96
11.1.6 Mar 25, 2011: Takeda Plans To Expand Sales Force And To Enhance Business Infrastructure In China 96
11.1.7 Mar 09, 2011: Medtronic Inaugurates New Manufacturing Facility In Singapore 97
11.1.8 Jan 17, 2011: Smiths Medical To Set Up Subsidiary In India 97
11.2 Government and Public Interest 98
11.2.1 Jun 15, 2011: Takeda To Start Internship Program For Tsinghua University Of China 98
11.2.2 Feb 21, 2011: Takeda Recalls Anti-Inflammatory Enzyme Preparation, Dasen In Japan 98
11.2.3 Jan 27, 2011: China’s Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 99

12 Appendix 100
12.1 Definitions of Markets Covered in the Report 101
12.1.1 Diabetes Care Devices 101
12.2 Research Methodology 102
12.3 Secondary Research 102
12.4 Primary Research 103
12.5 Models 103
12.6 Forecasts 104
12.7 Expert Panels 104
12.8 GlobalData Consulting 104
12.9 Currency Conversion 105
12.10 Contact Us 105
12.11 Disclaimer 105

List of Tables

Table 1:Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Table 2:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
Table 3:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Table 4:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15
Table 5:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
Table 6:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 17
Table 7:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 18
Table 8:Diabetes Care Devices, Asia-Pacific, Company share by Revenue ($m), USD Actual, 2009-2010 20
Table 9:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
Table 10:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Table 11:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
Table 12:Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
Table 13:Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010 26
Table 14:Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017 27
Table 15:Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010 28
Table 16:Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010 28
Table 17:Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Actual, 2009-2010 30
Table 18:Glucose Monitoring, Japan, Company share by Revenue ($m), USD Actual 2009-2010 32
Table 19:Insulin Delivery, Japan, Company share by Revenue ($m), USD Actual 2009-2010 34
Table 20:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
Table 21:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Table 22:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 37
Table 23:Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
Table 24:Diabetes Care Devices, India, Category Volume (Units), Historic, 2003-2010 39
Table 25:Diabetes Care Devices, India, Category Volume (Units), Forecast, 2010-2017 40
Table 26:Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 41
Table 27:Insulin Delivery, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 41
Table 28:Diabetes Care Devices, India, Company share by Revenue ($m), USD Actual, 2009-2010 43
Table 29:Glucose Monitoring, India, Company share by Revenue ($m), USD Actual 2009-2010 45
Table 30:Insulin Delivery, India, Company share by Revenue ($m), USD Actual 2009-2010 46
Table 31:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
Table 32:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 49
Table 33:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 51
Table 34:Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
Table 35:Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2003-2010 53
Table 36:Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2010-2017 54
Table 37:Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 38:Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 39:Diabetes Care Devices, Australia, Company share by Revenue ($m), USD Actual, 2009-2010 57
Table 40:Glucose Monitoring, Australia, Company share by Revenue ($m), USD Actual 2009-2010 59
Table 41:Insulin Delivery, Australia, Company share by Revenue ($m), USD Actual 2009-2010 61
Table 42:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
Table 43:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 64
Table 44:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66
Table 45:Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
Table 46:Diabetes Care Devices, China, Category Volume (Units), Historic, 2003-2010 69
Table 47:Diabetes Care Devices, China, Category Volume (Units), Forecast, 2010-2017 71
Table 48:Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72
Table 49:Insulin Delivery, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72
Table 50:Diabetes Care Devices, China, Company share by Revenue ($m), USD Actual, 2009-2010 74
Table 51:Glucose Monitoring, China, Company share by Revenue ($m), USD Actual 2009-2010 76
Table 52:Insulin Delivery, China, Company share by Revenue ($m), USD Actual 2009-2010 78
Table 53:Diabetes Care Devices Market Pipeline Products 88
Table 54:PositiveID Enters Into Agreement With HMD BioMedical 91
Table 55:Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 92
Table 56:ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 93
Table 57: USD to Local Currency, Asia-Pacific, Average Exchange Rate 2003-2010 105

List of Figures

Figure 1:Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Figure 2:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
Figure 3:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Figure 4:Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15
Figure 5:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
Figure 6:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 17
Figure 7:Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 18
Figure 8:Diabetes Care Devices, Asia-Pacific, Company share (%), 2010 19
Figure 9:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
Figure 10:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Figure 11:Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23
Figure 12:Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
Figure 13:Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010 26
Figure 14:Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017 27
Figure 15:Diabetes Care Devices, Japan, Company Share (%), 2010 29
Figure 16:Glucose Monitoring, Japan, Company share (%), 2010 31
Figure 17:Insulin Delivery, Japan, Company share (%), 2010 33
Figure 18:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
Figure 19:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Figure 20:Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 37
Figure 21:Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
Figure 22:Diabetes Care Devices, India, Category Volume (Units), Historic, 2003-2010 39
Figure 23:Diabetes Care Devices, India, Category Volume (Units), Forecast, 2010-2017 40
Figure 24:Diabetes Care Devices, India, Company share (%), 2010 42
Figure 25:Glucose Monitoring, India, Company share (%), 2010 44
Figure 26:Insulin Delivery, India, Company share (%), 2010 46
Figure 27:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
Figure 28:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 48
Figure 29:Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 50
Figure 30:Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
Figure 31:Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2003-2010 53
Figure 32:Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2010-2017 54
Figure 33:Diabetes Care Devices, Australia, Company share (%), 2010 56
Figure 34:Glucose Monitoring, Australia, Company share (%), 2010 58
Figure 35:Insulin Delivery, Australia, Company share (%), 2010 60
Figure 36:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
Figure 37:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 63
Figure 38:Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 65
Figure 39:Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
Figure 40:Diabetes Care Devices, China, Category Volume (Units), Historic, 2003-2010 68
Figure 41:Diabetes Care Devices, China, Category Volume (Units), Forecast, 2010-2017 70
Figure 42:Diabetes Care Devices, China, Company share (%), 2010 73
Figure 43:Glucose Monitoring, China, Company share (%), 2010 75
Figure 44:Insulin Delivery, China, Company share (%), 2010 77
Figure 45:F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 79
Figure 46:Novo Nordisk A/S, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 80
Figure 47:LifeScan, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 81
Figure 48:Eli Lilly and Company, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 82
Figure 49:ARKRAY, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 83
Figure 50:Medtronic, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 84

Other Related Reports

Japan Diabetes Care Devices Market Outlook to 2017

India Diabetes Care Devices Market Outlook to 2017

China Diabetes Care Devices Market Outlook to 2017

Australia Diabetes Care Devices Market Outlook to 2017

Filed in: Diabetes Care Device, Medical Device
More Reports
Title Price Buy Now

Global Insulin Pumps Market 2016-2020

Diabetes is a common metabolic disease in which an individual's blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes, the body does not produce sufficient insulin, and it is usually diagnosed in children and young adults. The most common type of diseases is type 2. In this type, the body is incapable of utilizing insulin. Insulin pump therapy is the most preferred alternative delivery method of administrating insulin instead of insulin pens and needles. It is able to reduce the rate of recurrence of severe hypoglycemia and is capable of improving the quality of life for insulin pump users. An ins......
$2500

Global Self-monitoring Blood Glucose Devices Market 2015-2019

Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment. The analysts forecast global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global self-monitoring blood glucose devices market for the period 2015-2019. To calculate the market size, The uses revenue generated from the sales of self-mon......
$2500

Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis

Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics. Companies covered Abbott, Alfred E. Mann Foundation for Science Research, Animas Corporation, Baxter, Bayer......
$2000

Global BGM Device Market 2014-2018

Diabetes is a disease that occurs when the body is unable to produce insulin, or when the glucose rises above the required levels. Insulin, a hormone produced by the pancreas, is used to process glucose, which acts as a fuel for the tissues. BGM is the process of testing the concentration of insulin or glucose in the blood. A blood glucose meter is a small electronic device used to measure and display the blood glucose level. To measure the level of blood glucose, a small drop of blood is taken by pricking a finger with an instrument called a lancet. The blood is then placed on a disposable blood glucose test strip and this is inserted into a blood glucose meter. TechNavio's analysts forecast the Global Blood Glucose Monitoring Device market to grow at a CAGR of 5.26 percent over the pe......
$2500

Global Continuous Glucose Monitoring Market 2014-2018

Continuous glucose monitoring is the measurement of glucose levels at regular intervals from a diabetic patient. Continuous glucose monitoring systems allow to gain insight into the trends of glucose levels between fingersticks, resulting in improved glucose control. Continuous glucose monitoring system comprises of a glucose sensor that is placed subcutaneously to provide the reading of glucose levels in tissue fluid. A transmitter sends information about the glucose levels using radio waves from the sensor to a receiver display. Continuous glucose monitoring system also offers additional information about HbA1C levels and fructosamine levels. TechNavio's analysts forecast the Global Continuous Glucose Monitoring market to grow at a CAGR of 14.74 percent over the period 2013-2018. C......
$2500

Global Mechanical Ventilators Market 2014-2018

A mechanical ventilator is a life-supporting medical device used to assist or replace a patient's breathing. A mechanical ventilation is generally the last resort for a patient who is having difficulty breathing and cannot maintain adequate oxygenation to maintain life. Patients with respiratory disorders such as COPD may require the need of mechanical ventilators. Mechanical ventilators can be positive pressure type and negative pressure type depending on the method of delivery of oxygen into the lungs by the ventilator. Positive pressure mechanical ventilators involve air (or another gas mix) being pushed into the trachea of the patient while with negative pressure mechanical ventilators the air is sucked inside. In general, mechanical ventilators are connected through an endotracheal tu......
$2500

North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

GlobalData’s new report, North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the North America Diabetes Care Devices market – Canada and United States. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. North America Diabetes Care Devices Market Outlook to 2017 Published:December 2011 No. of Pages: 106 Price $3500                                                              T......
$

Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

GlobalData’s new report, Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Europe Diabetes Care Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. Europe Diabetes Care Devices Market Outlook to 2017 Published:December 2011 No. of Pages: 115 Price $3500          This report is built using data and information sourced from proprietary databases, prim......
$